Antineoplastic PEG-rhG-CSF Txhaj

hauj lwm yam khoom

Antineoplastic PEG-rhG-CSF Txhaj for the patients of non-myeloablative malignancy with the treatment of antineoplastic, when may have clinic significance of febrile neutrophilic reduce myelosuppression, using this product to reduce the incidence rate of infection caused by febrile neutropenia. Antineoplastic PEG-rhG-CSF Txhaj yog tsis siv rau cov mobilization ntawm peripheral ntshav progenitor cell rau hematopoietic qia cell transplantation.

Tshuaj Lub npe

Generic lub npe. PEGylated kev siv Human Granulocyte Colony Stimulating Factor Txhaj

English lub npe. PEGylated kev siv Human Granulocyte Colony Stimulating Factor Txhaj

Antineoplastic PEG-rhG-CSF Txhaj hauj lwm

cov kua ntshiab ntshiab

Antineoplastic PEG-rhG-CSF TxhajIndications

1. Nws yog siv rau cov neeg mob uas tsis yog-myeloablative malignancy nrog cov kev kho mob ntawm antineoplastic, thaum yuav muaj lub tsev kho mob tseem ceeb ntawm febrile neutrophilic txo myelosuppression, siv cov khoom no los txo cov xwm txheej tus nqi ntawm kab mob tshwm sim los ntawm febrile neutropenia.

2. Cov khoom no tsis siv rau cov mobilization ntawm peripheral ntshav progenitor cell rau hematopoietic qia cell transplantation.

Antineoplastic PEG-rhG-CSF Txhaj Contraindication

Nws yog txwv tsis pub rau kev tsis haum rau PEG-rhG-CSF, rhG-CSF thiab e.coli qhia ntawm lwm yam preparations.The cov neeg mob uas serous siab, raum, lub plawv, mob ntsws kuj yog xiam oob qhab.

Antineoplastic PEG-rhG-CSF Txhaj khoom duab

Antineoplastic PEG-rhG-CSF Txhaj Tsheb thauj mus los thiab ntsiab lus uas them

specification 3 mg/ml

Ntim 1 bottle/box

npaj txhaj tshuaj